2005 Superfund Basic Research Program Annual Meeting
Chromate and Polycyclic Aromatic Hydrocarbon Interactions
(Transcriptional Repression by Chromium-Chromatin Interactions)
Alvaro PugaDepartment of Environmental Health
University of Cincinnati
Why study mixtures of PAHs and metals?
As, Cr, B(a)P and PCBs are in USEPA top 20 hazardous substance priority list
9,727 Superfund sites with PAH contamination;2,539 have also Cr; 2,274 have also As
1,200 sites in National Priority List; 40% have Cr/As and PAHs.
Is there enough time in the combined lifetimesOf all biological scientists to study all mixtures?
275 CERCLA compounds
37,675 binary combinations3,428,425 ternary combinations
233,132,900 quaternary combinations…
175,000 biological scientists (Latest NSF estimates)
To study complex mixtures we need a different experimental paradigm
For binary mixtures:
Cross-talking signaling pathways
How does one member of the mixturemodify the effect of the other?
Ah Receptor-Dependent Transactivation and Target Gene Expression in the presence of Cr
Cytosol
Nucleus
TCDD AHR
B[a]P
TCDD
MAPK pathways
?
AIP
AhRECYP1A1
AHR
Hsp90p23 ARNT
C Cr?
Mouse Hepa-1 cells
Cr inhibits inducible gene expression
• Cr-DNA crosslinks• Cr-DNA adducts
Zhitkovich (2005) Chem.Res.Tox. 18:3-11
• Disruption of transcriptional complexes
• MT, PEPCK, but not actinHamilton et al (1989) Mol.Carcinog. 2:274-286
• Blocks binding of p300 to NFkB p65Shumilla et al (1999) J.Biol.Chem. 274:36207-36212
• Chromium Speciation and Distribution
• Transrepression of AHR-inducible Genes by Chromium
• Epigenetics of Chromium-Chromatin Interactions
Chromium speciation by HPLC/ICP-MS
Cr(VI)
e-
Cr(V)
e-
Cr(IV)
e-
Cr(III)
K2CrO4
K2Cr2O7
a) t = 0 b) t = 1 h
Chromium distribution to nuclei and cytoplasm
ICP-MS
nucleicytoplasm
K2Cr2O7
nucleicytoplasm
K2CrO4Cell Fraction
ng C
r per
100
mm
pla
te0
50
100
150
200
250
51Cr Uptake
0
2
4
6
8
nuclei cytoplasmCell Fraction
dpm
per 1
00 m
m p
late
(X10
7 )
DMSOBaP
As, Cd and Cr affect AHR-dependent gene expression differently in Hepa-1 cells
The effect of Chromium on AHR-dependent gene expression is transcriptional
CYP1A1 GSTa GSTp
Rel
ativ
e m
RN
A le
vel
0
1
2
3
4
5 DMSOBaPCr+BaPBaP+Cr, nuclei
Rel
ativ
e m
RN
A le
vel
0.0
0.2
0.4
0.6
0.8
1.0
1.2
0 5 25 50
BaP + + + +
µM Cr
Cr represses only inducible gene expression
B[a]P-induced CYP1A1 mRNA in Human HepG2 cells
0
20
40
60
80
100
120
DMSO Cr BaP Cr+BaP
Fold
indu
ctio
n
*
+
00.20.40.60.8
11.21.41.6
DMSO Cr BaP Cr+BaP
Fold
indu
ctio
n
00.20.40.60.8
11.21.4
DMSO Cr BaP Cr+BaP
Fold
indu
ctio
n
BaP: Benzo[a]pyrene (5 µM, 8h)Cr: chromium (50 µM, 9h) Cr+BaP: Cr (50 µM, 1h) + BaP (5 µM, 8h)
* p<0.01 Vs DMSO, + p<0.01 Vs BaP
CYP1A1
CYP1A2 CYP1B1
p1647LUCin Hepa-1 cells
Cr is less effective if added after AHR activation
DMSO Cr -2 h -0.5 h 0 h 0.5 h 2 h
Rel
ativ
e lu
cife
rase
act
ivity
0.0
0.2
0.4
0.6
0.8
1.0
+ TCDD
* **
* *
*
*
+ BaP
Cr affects the expression profiles of BaP-induced genes
1.00
10.00
100.00
Control BaP Cr+BaP BaP+Cr
Treatment
Fold
Cha
nge
from
Con
trol
AB025408
AF006482
AF016294
AJ297743AK002894
AK007683
BC003982
L06047
L24118
M32032
NM009992NM025797
U12785
U12961
U23921
U38261
U40796
U75215U85498
U96441
X91825
EsteraseTP dyphosphohydrolaseE74-like factor 3
Torsin 1 B
P gluc oxygenase
TNF-related
RIKEN cDNA 1110035H23
GST alpha 4
TNF alpha induced
Selenium binding protein 1
CYP1A1
RIKEN-NM025797ALDH3A1
NQO1
Osmotic stress protein
SOD3
Excision repair comp.grp5
Amino acid transporter
GCLC
Numb-like
Small proline-rich protein
Profiles of Other BaP-Induced Genes
0
0.5
1.0
1.5
2.0
2.5
Control BaP Cr+BaP BaP+Cr
Treatment
Fold
Cha
nge
from
Con
trol
AB041604AB041657AB049653AB055070AF012923AF124725AF232709AK003562AK004305AK004431AK005192AK005691AK008611AK009025AK010334AK010545AK012430AK013765BC003237BC004041BC004667D49439NM010590NM023665NM023685NM025498NM025964NM025982NM026373NM026494NM029385NM030564U21960Z11911
Hypothetical protein MNCb-5081Hypothetical protein, MNCb-2990Mitochondrial ribosomal protein L34Clone MGC:7904Wild-type p53-induced gene 1Apoptotic chromatin condensation Syntaxin 5CDC42 EFFECTOR PROTEIN 2SNAP25 INTERACTING PROTEIN 30Di-George syndrome related protein Translation factor SUI1homolog GC20Zinc finger protein 2RIKENUbiquitin-like protein SB132RIKEN-BBP-like protein 1Downstream of tyrosine kinase 5Endothelial cell growth factor 1Similar to ATP/GTP-binding proteinPeptidylprolyl isomerase F (cyclophilin F)Clone IMAGE:3498604TBP-associated factorAjubaRIKENSCAN-KRAB-zinc finger gene 1RIKEN-RIKEN-RIKEN-RIKEN-RIKENRIKEN-Hypothetical protein MGC7670Calcium modulating ligandGlucose-6-phosphate dehydrogenase
TCDD activates the AHR to a DNA-binding configuration in the presence of Cr
St
In the presence of Cr AHR binds to DNA but transcription is inhibited
Several co-regulators increase BaP-inducedgene expression and their effect is blocked by Cr
50000
100000
150000
200000
250000
0Bluescript SRC-1 SRC-2 p300 BRG-1
Luc/β-
gal
DMSOBaP BaP+25 µM CrBaP+50 µM Cr
Chromium interferes with co-activator recruitment and chromatin structure
-1200 -1000 -800 -600 -400 -200 +1
Endogenous Cyp1a1
Integrated AhRDtkLuc tk
NaB blocks the Inhibition by Cr of BaP-
induced gene expression …. But inhibition takes place at the level of the
immediate promoter
ChIP for AHR and ARNT
α-AHR α-ARNT
Fold
cha
nge
D Cr B Cr+B D Cr B Cr+B02468
1012
0.00.51.01.52.02.53.0
D Cr B Cr+B D Cr B Cr+Bα-AHR α-ARNT
D Cr B Cr+B D Cr B Cr+B
α-AHR
α-ARNT
A Enhancer Proximal promoter
-1200 -1000 -800 -600 -400 -200 +1
-1141 -784 +71-291Cyp1a1
ChIP for p300 and HDAC-1
Fold
cha
nge
0.00.51.01.52.02.5
D Cr B Cr+B D Cr B Cr+B0.0
0.5
1.0
1.5
2.0
2.5
D Cr B Cr+B D Cr B Cr+Bα-p300 α-HDAC1 α-p300 α-HDAC1
α-p300
α-HDAC1
Enhancer Proximal promoter
D Cr B Cr+B D Cr B Cr+B
B
-1200 -1000 -800 -600 -400 -200 +1
-1141 -784 +71-291Cyp1a1
Effect of Cr on AHR-inducible genes
HDAC-1
AHR ARNT
p300 TFIIsRNAPol II
HDAC-1
Ligand induction
HDAC-1AHR ARNT
Cr
Ligand inductionIn the presence of Cr
Cyp1a1
HDAC-1
HDAC-1
Cr crosslinks HDAC-1 to the Cyp1a1 promoter in Hepa-1 cells
0.0
0.5
1.0
1.5
2.0
DMSO BaP
αAH
R%
of t
otal
inpu
t
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7enhancerproximal promoter
αHD
AC
-1%
of t
otal
inpu
t
FHO + + - - + + - - + -EDTA + - + - + - + - + +
DMSO Cr BaP
CYP1A1 enhancer αHDAC-1
Input
FHO + + - - + + - - + -EDTA + - + - + - + - + +
DMSO Cr BaP
DMSO
BaP
αAHR
Input
CYP1A1 promoterInput
αHDAC-1
Input
αAHR
50 µM Cr, 2h; 5 µM BaP, 2hn=3
DNA demethylation by 5-azacytidine inhibits Cr effects
0
5
10
15
0
20
40
60
80
100DMSO Cr BaP Cr+BaP
20 1µM 5-AzaC
Rel
ativ
e C
YP1A
1 m
RN
AR
elat
ive
NQ
O1
mR
NA
5AzaC: 56h BaP: 5 µM, 8hCr: 50 µM, 9h Cr+BaP: Cr (1h) + BaP (8h)
Effect of Cr on AHR-inducible genes
HDAC-1
AHR ARNT
p300 TFIIsRNAPol II
HDAC-1
Ligand induction
HDAC-1AHR ARNT
Cr
Ligand inductionIn the presence of Cr
Cyp1a1
HDAC-1
HDAC-1
Conclusions and Questions
Cr inhibits BaP inducible gene expression bykeeping HDAC-1 bound to chromatin and derailing methylation/demethylation patterns in promoters
Does chromium affect epigenetic imprinting?
How generalized is this mechanism?
Kathy Tepperman Yu-Dan Wei Ming-ya Huang
(R01 ES10807, P42 ES04908)
Michael Schnekenburger
GSH depletion or replenishment does not affect significantly inhibition by Cr of the expression of an AHR reporter
-1200 -1000 -800 -600 -400 -200 +1
p1647Luc LucR
elat
ive
luci
fera
se a
ctiv
ity
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
DMSOTCDD Cr
Cr+TCDD
DMSOTCDD Cr
Cr+TCDD
DMSOTCDD Cr
Cr+TCDD
DMSO 20 µM BSO 5 mM NAC